Stay updated with breaking news from Neuroscience Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and... | May 1, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in the Cellular Therapeutics in Trauma and Critical Care’s (CTTACC) conference, “Cellular Therapies and Tran...
Athersys Provides MultiStem Clinical Update - read this article along with other careers information, tips and advice on BioSpace
Heather Sudduth is the Coordinator of Neuroscience Programs at Singing River Health System. As Coordinator of Neuroscience Programs, Heather was instrumental in the development of their stroke program. She has
Corporate restructuring underway and MASTERS-2 clinical trial prioritizedConference call begins at 4:30 p.m. Eastern time todayCLEVELAND--(BUSINESS WIRE)--$ATHX #ARDS--Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three and six months ended June 30, 2022 and provided a business update.S...